As of 2024-12-12, the Fair Value of Zentalis Pharmaceuticals Inc (ZNTL) is -12.58 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.50 USD, the upside of Zentalis Pharmaceuticals Inc is -459.37%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -45.66 | -117.84 | -158.73 | -236.81 | -292.19 | -170.25 |
| YoY growth | -116.71% | -158.08% | -34.70% | -49.19% | -23.39% | -76.41% |
| Market Cap (mil) | 249.44 |
| P/E | |
| Forward P/E |
| EPS | -2.52 |
| Avg earnings growth rate | -76.41% |
| TTM earnings | -179.28 |